PMC4009157_01
In different sections (above and bottom) regressing of metastatic nodules in the lungs ((a) and (d), at onset; (b) and (e), October; (c) and (f), December); note the cavitations in (e) and (f).
CRIONM2014-731581.001.jpg
PMC4009157_01_CRIONM2014-731581.001.jpg
fig1
After screening for staging, the patient was found to have multiple lung and hepatic metastases (Figures 1(a) and 1(d); Figures 2(a) and 2(d)). After 2 cycles of TCH we achieved partial response (October 2012) (Figures 1(b) and 1(e); Figures 2(b) and 2(e)). After 6 cycles we achieved further partial response (December 2012) (Figures 1(c) and 1(f); Figures 2(c) and 2(f)).
In different sections (above and bottom) regressing of metastatic lesions in the liver ((a) and (d), at onset; (b) and (e), October; (c) and (f), December); note the calcifications in (c) and (f).
CRIONM2014-731581.002.jpg
PMC4009157_01_CRIONM2014-731581.002.jpg
fig2
After screening for staging, the patient was found to have multiple lung and hepatic metastases (Figures 1(a) and 1(d); Figures 2(a) and 2(d)). After 2 cycles of TCH we achieved partial response (October 2012) (Figures 1(b) and 1(e); Figures 2(b) and 2(e)). After 6 cycles we achieved further partial response (December 2012) (Figures 1(c) and 1(f); Figures 2(c) and 2(f)).
Complete response in July 2013 in the lungs and liver.
CRIONM2014-731581.003.jpg
PMC4009157_01_CRIONM2014-731581.003.jpg
fig3
The clinical appearance of complete response was rather unusual which we have not seen before in our past clinical experience, with cavitations on lungs and calcifications on liver (Figure 3). On the last follow-up visit on July 2013 (Figure 3) complete response has been achieved.